Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
Not Applicable
Recruiting
- Conditions
- Malignant Neoplasm of Breast
- Interventions
- Device: Novilase Laser ablation
- First Posted Date
- 2018-03-13
- Last Posted Date
- 2024-04-02
- Lead Sponsor
- Novian Health Inc.
- Target Recruit Count
- 122
- Registration Number
- NCT03463954
- Locations
- 🇨ðŸ‡
Breast Centre Zurich, Zurich, Switzerland
🇺🇸Summit Health, Florham Park, New Jersey, United States
🇺🇸Yale University, New Haven, Connecticut, United States
A Multicenter "Ablate and Resect" Study of Novilase® Interstitial Laser Therapy for the Ablation of Small Breast Cancers
Not Applicable
- Conditions
- Malignant Tumor
- Interventions
- Device: Novilase Interstitial Laser Therapy
- First Posted Date
- 2011-11-23
- Last Posted Date
- 2021-03-03
- Lead Sponsor
- Novian Health Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT01478438
- Locations
- 🇺🇸
Rose Medical Center - Rose Breast Center, Denver, Colorado, United States
🇺🇸St. Alexius Breast Care of St. Alexius Medical Center, Bartlett, Illinois, United States
🇺🇸Advocate Lutheran General Hospital - Caldwell Breast Center, Park Ridge, Illinois, United States
American Breast Laser Ablation Therapy Evaluation
Completed
- Conditions
- Benign Breast Conditions; Breast Fibroadenomas
- First Posted Date
- 2008-12-12
- Last Posted Date
- 2023-08-04
- Lead Sponsor
- Novian Health Inc.
- Target Recruit Count
- 108
- Registration Number
- NCT00807924
- Locations
- 🇺🇸
Columbia University Medical Center - Department of Surgery, New York, New York, United States
© Copyright 2025. All Rights Reserved by MedPath